A retrospective study evaluating Bamlanivimab for Covid-19 in Kidney Transplant Patients
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Bamlanivimab (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2021 New trial record
- 09 Jun 2021 Results presented at the 2021 American Transplant Congress